
Sign up to save your podcasts
Or
Finally got around to tackling rituximab in SLE. This is a tough topic: lots of people feel passionately one way or another, flawed observational data supports its use, flawed RCTs did not find significant benefit, and patients are left in the lurch. I tried my best and came away more confident than ever that there's no clear answer. I hope you enjoy; please send me feedback on twitter @ebrheum!
4.9
111111 ratings
Finally got around to tackling rituximab in SLE. This is a tough topic: lots of people feel passionately one way or another, flawed observational data supports its use, flawed RCTs did not find significant benefit, and patients are left in the lurch. I tried my best and came away more confident than ever that there's no clear answer. I hope you enjoy; please send me feedback on twitter @ebrheum!
315 Listeners
497 Listeners
124 Listeners
3,323 Listeners
1,103 Listeners
119 Listeners
195 Listeners
516 Listeners
349 Listeners
168 Listeners
70 Listeners
4 Listeners
174 Listeners
6 Listeners
19 Listeners